About SonoScape

About SonoScape Medical Corporation

History and Commitment to Excellence

Founded in 2002, SonoScape Medical Corporation is a leading provider of innovative medical solutions, specializing in ultrasound systems, endoscopy, and in-vitro diagnostics. Headquartered in Shenzhen, China, SonoScape has rapidly gained global recognition for delivering high-performance medical devices designed to improve healthcare accessibility and quality worldwide. In 2017, the company was publicly listed on the Shenzhen Stock Exchange, a milestone marking its strong commitment to growth and excellence in the medical technology field.

Research and Development (R&D)

SonoScape has a robust global R&D network with centers in key locations such as Shenzhen, Shanghai, and internationally in San Francisco and Tokyo. The company reinvests approximately 20% of its revenue into research and development, fueling continuous innovation. With over 800 R&D professionals globally, SonoScape remains at the forefront of medical technology, creating advanced solutions like the X5 ultrasound, which became the first imaging device aboard the Chinese space station in 2021.

Products and Market Reach

Known for its expertise in diagnostic ultrasound, SonoScape has expanded its product lines to include endoscopy systems, minimally invasive surgery solutions, and cardiovascular intervention tools. Its products are available in over 170 countries and regions, supporting healthcare facilities across the globe. SonoScape has built a reputation for reliability and high-quality imaging, winning accolades such as Frost & Sullivan’s “Ultrasound Market Leadership Award.”

Vision for the Future

SonoScape is dedicated to advancing healthcare technologies and making innovative medical devices more accessible. With ongoing investments in core technologies and a focus on emerging healthcare needs, the company is poised to continue delivering impactful solutions, meeting the demands of both present and future healthcare environments.